• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

ADA Asks Trump to Consider Reforms in 2017

Article

In too many cases unnecessary federal regulations contribute to the cost of providing care making it more difficult for our members to deliver oral health care services at an affordable price, the American Dental Association wrote in a letter to the Trump administration.

, the American Dental Association (ADA) has asked that the administration consider several oral healthcare reforms in 2017 that could affect the dental profession nationwide. The letter is a result of the Association’s belief that “in too many cases unnecessary federal regulations contribute to the cost of providing care making it more difficult for our members to deliver oral health care services at an affordable price.”

In the letter, the ADA requested that the administration review several current health care regulations that, they suggest, must be rescinded or amended to lessen the adverse impact and burden on dental professionals and their patients. Several health care regulations were highlighted in the letter, and recommendations for improvement from the ADA were included:

· Ordering and Referring (Medicare) — Dentists that do not participate in Medicare should be exempt from the Medicare Ordering and Referring requirements.

· Medicare Part D — Dentists and other health care professionals who do not participate in Medicare should be excluded from Medicare Part D enrollment requirements.

· Affordable Care Act, Section 1557 — The ADA recommends Section 1557 simply be enforced as is by the Office of Civil Rights without the formal publication of regulations. Section 1557 pertains to nondiscrimination in health care environments. If this regulation is not rescinded, the ADA recommends an exemption for small businesses with less than 25 employees.

· Requirement for providers participating in Medicare Advantage Programs to enroll in Medicare — Recommendations from the ADA include full repeal of this regulation to ensure providers of covered services in Medicare Advantage plans may continue to treat patients who choose to use their services, even if they are out-of-network providers.

· Substance Abuse and Mental Health Services Administration — In response to a proposed expansion of regulations to cover health care practices providing substance abuse disorder diagnoses, treatments, or referrals, the ADA is asking the incoming administration to exempt dental practices from this requirement if a full repeal of this rule is impossible.

The ADA concluded the letter by saying the organization “is looking forward to working with the Trump Administration on a great many issues affecting oral health care in America.”

Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: Diving Deep on J. Morita's New Root ZX3 & HF Module
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
Related Content
© 2024 MJH Life Sciences

All rights reserved.